TR201901268T4 - Mesenchymal stem cells and their uses. - Google Patents
Mesenchymal stem cells and their uses. Download PDFInfo
- Publication number
- TR201901268T4 TR201901268T4 TR2019/01268T TR201901268T TR201901268T4 TR 201901268 T4 TR201901268 T4 TR 201901268T4 TR 2019/01268 T TR2019/01268 T TR 2019/01268T TR 201901268 T TR201901268 T TR 201901268T TR 201901268 T4 TR201901268 T4 TR 201901268T4
- Authority
- TR
- Turkey
- Prior art keywords
- stem cells
- mesenchymal stem
- methods
- animal
- diseases
- Prior art date
Links
- 210000002901 mesenchymal stem cell Anatomy 0.000 title abstract 3
- 230000001737 promoting effect Effects 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 210000001557 animal structure Anatomy 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
To provide novel uses of mesenchymal stem cells.SOLUTION: The present invention discloses methods for treating animal autoimmune diseases, allergic diseases, cancer, or inflammatory diseases, methods for promoting wound healing, and methods promoting angiogenesis in animal organs and tissues by administering an effective amount of animal mesenchymal stem cells.SELECTED DRAWING: None
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55511804P | 2004-03-22 | 2004-03-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201901268T4 true TR201901268T4 (en) | 2019-02-21 |
Family
ID=46060822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/01268T TR201901268T4 (en) | 2004-03-22 | 2005-03-15 | Mesenchymal stem cells and their uses. |
Country Status (6)
| Country | Link |
|---|---|
| JP (8) | JP6114500B2 (en) |
| AT (1) | ATE556134T1 (en) |
| CA (3) | CA2934682C (en) |
| ES (7) | ES2708627T3 (en) |
| HK (2) | HK1205531A1 (en) |
| TR (1) | TR201901268T4 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2708627T3 (en) * | 2004-03-22 | 2019-04-10 | Mesoblast Int Sarl | Mesenchymal stem cells and their uses |
| US20150110751A1 (en) * | 2012-05-16 | 2015-04-23 | Kennedy Krieger Institute, Inc. | Stem cells as an individualized maternal therapy for prevention of prematurity |
| JP2016210730A (en) * | 2015-05-08 | 2016-12-15 | 上田 実 | Pharmaceutical compositions and production methods thereof as well as pharmaceuticals |
| CN109952371A (en) | 2016-11-15 | 2019-06-28 | 株式会社钟化 | Cell mass, preparation method and medical composition comprising the mesenchyma lineage stem cells from fetal appendage |
| WO2019132026A1 (en) | 2017-12-28 | 2019-07-04 | 株式会社カネカ | Cell population including adhesive stem cells, production method therefor, and pharmaceutical composition |
| US20220233600A1 (en) | 2019-06-14 | 2022-07-28 | Kaneka Corporation | Cell population comprising mesenchymal cells, pharmaceutical composition comprising the same, and method for producing the same |
| CA3148582A1 (en) * | 2019-08-15 | 2021-02-18 | Nextcell Pharma Ab | Allogeneic composition for treatment of cns disorders |
| CN113813288B (en) * | 2021-08-11 | 2024-02-13 | 谢岩 | Application of mesenchymal stem cells and composition containing mesenchymal stem cells in preparation of medicine for treating burn wound difficult to heal |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0651641B2 (en) * | 1983-08-29 | 1994-07-06 | 株式会社ミドリ十字 | Gamma interferon composition |
| WO1987005518A1 (en) * | 1986-03-17 | 1987-09-24 | Schering Corporation | Treatment of cancers with gamma interferon |
| CA2191733A1 (en) * | 1994-06-07 | 1995-12-21 | Daniel A. Vallera | Methods for inhibiting antigen specific t cell responses |
| CA2253724A1 (en) * | 1996-04-26 | 1997-11-06 | Case Western Reserve University | Skin regeneration using mesenchymal stem cells |
| US6368636B1 (en) * | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| DE69929681T2 (en) * | 1998-03-18 | 2006-10-26 | Osiris Therapeutics, Inc. | MESENCHYMAL STEM CELLS FOR THE PREVENTION AND TREATMENT OF IMMUNE RESPONSES IN TRANSPLANTATIONS |
| PT1066060E (en) * | 1998-04-03 | 2003-12-31 | Osiris Therapeutics Inc | MESENCHINEAL STAMINA CELLS AS IMMUNOSUPRESSORS |
| CN101053573A (en) * | 2000-01-19 | 2007-10-17 | 帕卡什·S·吉尔 | Compositions and methods based on VEGF antisense oligonucleotides |
| EP1276486B2 (en) * | 2000-04-25 | 2014-03-05 | Osiris Therapeutics, Inc. | Joint repair using mesenchymal stem cells |
| DK2311869T3 (en) * | 2002-02-01 | 2013-03-18 | Merck Sharp & Dohme | Use of mammalian cytokine-related reagents |
| JP3897343B2 (en) * | 2002-08-01 | 2007-03-22 | 株式会社林原生物化学研究所 | Protein that induces production of interferon-γ in immunocompetent cells |
| JP4672370B2 (en) * | 2002-12-05 | 2011-04-20 | ケース ウエスタン リザーブ ユニバーシティ | Cell-based treatment of ischemia |
| ES2708627T3 (en) * | 2004-03-22 | 2019-04-10 | Mesoblast Int Sarl | Mesenchymal stem cells and their uses |
| JP2007530543A (en) * | 2004-03-22 | 2007-11-01 | オシリス セラピューティクス，インコーポレイテッド | Mesenchymal stem cells and use thereof |
-
2005
- 2005-03-15 ES ES14172800T patent/ES2708627T3/en active Active
- 2005-03-15 CA CA2934682A patent/CA2934682C/en active Active
- 2005-03-15 CA CA2868733A patent/CA2868733C/en active Active
- 2005-03-15 ES ES10011225.9T patent/ES2544689T3/en active Active
- 2005-03-15 CA CA3135582A patent/CA3135582A1/en active Pending
- 2005-03-15 ES ES05725577T patent/ES2385450T3/en active Active
- 2005-03-15 ES ES10011223.4T patent/ES2643030T3/en active Active
- 2005-03-15 TR TR2019/01268T patent/TR201901268T4/en unknown
- 2005-03-15 ES ES10011226.7T patent/ES2645018T3/en active Active
- 2005-03-15 AT AT05725577T patent/ATE556134T1/en active
- 2005-03-15 ES ES10011224.2T patent/ES2643076T3/en active Active
- 2005-03-15 ES ES14172807T patent/ES2657382T5/en active Active
-
2012
- 2012-03-15 JP JP2012058539A patent/JP6114500B2/en active Active
-
2014
- 2014-11-28 JP JP2014241859A patent/JP5997237B2/en active Active
-
2015
- 2015-06-29 HK HK15106165.9A patent/HK1205531A1/en unknown
- 2015-06-29 HK HK15106166.8A patent/HK1205677A1/en unknown
-
2017
- 2017-01-13 JP JP2017003854A patent/JP6382360B2/en active Active
- 2017-08-10 JP JP2017155229A patent/JP6757300B2/en active Active
-
2018
- 2018-10-09 JP JP2018190636A patent/JP6757383B2/en active Active
-
2020
- 2020-03-18 JP JP2020047240A patent/JP7033159B2/en active Active
-
2021
- 2021-08-30 JP JP2021140167A patent/JP2021191771A/en active Pending
-
2023
- 2023-02-20 JP JP2023023996A patent/JP2023065486A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018009002A (en) | 2018-01-18 |
| CA3135582A1 (en) | 2005-10-06 |
| ATE556134T1 (en) | 2012-05-15 |
| ES2657382T3 (en) | 2018-03-05 |
| ES2645018T3 (en) | 2017-12-01 |
| ES2643076T3 (en) | 2017-11-21 |
| JP2021191771A (en) | 2021-12-16 |
| JP2017080507A (en) | 2017-05-18 |
| JP2015061862A (en) | 2015-04-02 |
| JP7033159B2 (en) | 2022-03-09 |
| JP6114500B2 (en) | 2017-04-12 |
| JP2020111591A (en) | 2020-07-27 |
| CA2934682A1 (en) | 2005-10-06 |
| JP2012176948A (en) | 2012-09-13 |
| CA2934682C (en) | 2021-12-07 |
| JP2019014747A (en) | 2019-01-31 |
| CA2868733C (en) | 2019-12-17 |
| ES2385450T3 (en) | 2012-07-25 |
| JP6757300B2 (en) | 2020-09-16 |
| JP6382360B2 (en) | 2018-08-29 |
| HK1205677A1 (en) | 2015-12-24 |
| ES2708627T3 (en) | 2019-04-10 |
| JP2023065486A (en) | 2023-05-12 |
| CA2868733A1 (en) | 2005-10-06 |
| JP6757383B2 (en) | 2020-09-16 |
| ES2657382T5 (en) | 2021-07-12 |
| ES2643030T3 (en) | 2017-11-21 |
| JP5997237B2 (en) | 2016-09-28 |
| ES2544689T3 (en) | 2015-09-02 |
| HK1205531A1 (en) | 2015-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1205531A1 (en) | Mesenchymal stem cells and uses therefor | |
| EP2298861A3 (en) | Mesenchymal stem cells and uses therefor | |
| WO2008116157A3 (en) | Mesenchymal stem cells and uses therefor | |
| EA200700175A1 (en) | COMPOSITIONS AND METHODS OF TREATING INFLAMMATORY DISEASES | |
| ATE489957T1 (en) | AGENTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
| AR061171A1 (en) | PROTEINS OF UNION TO THE GROWTH FACTOR OF HEPATOCITS (FCH) | |
| CY1118073T1 (en) | COMPOSITIONS AND METHODS FOR INCREASING THE TELECOMMUNICATION ACT | |
| CR20110230A (en) | INHIBITORS OF PROTEIN CINASE ENZYMES ACTIVATED BY MYTHOGEN P38 | |
| MX2007004551A (en) | Thiadiazole compounds and methods of use. | |
| TW200738657A (en) | Thiazole compounds and methods of use | |
| UY28396A1 (en) | VEGF TRUMPS AND THERAPEUTIC USES OF THE SAME | |
| NO20092637L (en) | Methods of treatment | |
| EA200870019A1 (en) | LACTAMIC CONNECTIONS AND METHODS OF THEIR APPLICATION | |
| ECSP11010949A (en) | INHIBITORS OF CINASE PROTEIN ENZYMES ACTIVATED BY MITOGEN P38 | |
| ATE531382T1 (en) | TREATMENT METHODS OF INFLAMMATORY DISEASES WITH ACTIVE INGREDIENTS SPECIFICALLY BINDING TO HUMAN ANGIOPOIETIN-2 | |
| ITMI20041550A1 (en) | USE OF PROBIOTIC BACTERIA FOR THE PREPARATION OF TOPICAL COMPOSITIONS FOR THE PROTECTION OF THE EPIDERMIS | |
| DE602005026866D1 (en) | USE OF THREE-DIMENSIONAL CULTURED TISSUE FOR THE TREATMENT OF CONGESTIVE HEART FAILURE | |
| EA201071059A1 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATION AND PATHOLOGICAL CONDITIONS RELATED TO THE INFLAMMATION | |
| EA200971053A1 (en) | METHODS OF TREATMENT OF THE LEAD ULCERS | |
| CY1119317T1 (en) | COMPOSITION FOR LOCAL APPLICATION, USE OF THESE, APPLIANCES AND PART KITS | |
| MX2007010484A (en) | Molecules and methods of using same for treating mcp-1/ccr2 associated diseases. | |
| DE602006011959D1 (en) | NA +, K + -ATPASE EXPRESSION IN ZERVIX DYSPLASIA AND CANCER | |
| BRPI0519218A2 (en) | hair growth reduction | |
| ATE446098T1 (en) | USE OF POLYETHYLENE GLYCOL IN INFLAMMATORY TOPICAL DISEASES OR DISEASES AND WOUND HEALING | |
| DE502005005652D1 (en) | Heterocyclic sub-substituted nononepipepidites |